These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1337424)

  • 1. Leukotriene B4 and platelet-activating factor in human skin.
    Michel L; Dubertret L
    Arch Dermatol Res; 1992; 284 Suppl 1():S12-7. PubMed ID: 1337424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic properties of LTB4 and paf-acether in vivo in human skin.
    Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
    J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP; McColl SR; Braquet P; Borgeat P
    Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paf-acether in human skin.
    Denizot Y; Michel L; Benveniste J; Meybeck A; Thomas Y; Dubertret L
    Lipids; 1991 Dec; 26(12):1093-4. PubMed ID: 1819692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
    Thomsen MK; Larsen CG; Thomsen HK; Kirstein D; Skak-Nielsen T; Ahnfelt-Rønne I; Thestrup-Pedersen K
    J Invest Dermatol; 1991 Feb; 96(2):260-6. PubMed ID: 1846901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.
    Cluzel M; Undem BJ; Chilton FH
    J Immunol; 1989 Dec; 143(11):3659-65. PubMed ID: 2555414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4.
    Hopkins NK; Lin AH; Gorman RR
    Biochim Biophys Acta; 1983 Oct; 763(3):276-83. PubMed ID: 6313071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes.
    Kragballe K; Desjarlais L; Voorhees JJ
    Br J Dermatol; 1985 Jul; 113(1):43-52. PubMed ID: 2990516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor- and leukotriene B4-induced release of lactoferrin from blood neutrophils of atopic and nonatopic individuals.
    Taylor MB; Zweiman B; Moskovitz AR; von Allmen C; Atkins PC
    J Allergy Clin Immunol; 1990 Nov; 86(5):740-8. PubMed ID: 2172350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
    Hopkins NK; Schaub RG; Gorman RR
    Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
    Ford-Hutchinson AW
    Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig.
    Handley DA; Farley C; Deacon RW; Saunders RN
    Prostaglandins Leukot Med; 1986 Mar; 21(3):269-77. PubMed ID: 3010331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.
    Foster AP; Lees P; Cunningham FM
    Res Vet Sci; 1992 Sep; 53(2):223-9. PubMed ID: 1332153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of human eosinophil migration towards platelet-activating factor and leukotriene B4.
    Czarnetzki BM; Csatò M
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):191-3. PubMed ID: 2540094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
    J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.